Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1Phase EARLY_PHASE1 1

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 1Breast 1

Conditions

Gastrointestinal Hemorrhage 1Colorectal Neoplasms 1Breast Neoplasms 1

Interventions

Cisplatin 1519Carboplatin 1420Cyclophosphamide 1360Gemcitabine 1235Bevacizumab 1226Paclitaxel 1211Radiotherapy 1176Docetaxel 1080pembrolizumab 1028Oxaliplatin 936Capecitabine 900Fluorouracil 833Rituximab 729Doxorubicin 683Nivolumab 679Dexamethasone 666Etoposide 660Irinotecan 622Leucovorin 575Pemetrexed 510Drug Therapy 493Cetuximab 483Trastuzumab 469Cytarabine 466Magnetic Resonance Spectroscopy 458Filgrastim 446Prednisone 432Lenalidomide 409Specimen Handling 408Temozolomide 400

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Deamino Arginine Vasopressin × Clear all
NCT01623206 2017-08-24

Desmopressin (DDAVP) in Patients With Colorectal Cancer and Rectal Bleeding

Laboratorio Elea Phoenix S.A.

Phase 2 Completed
30 enrolled
Gastrointestinal

Gastrointestinal Hemorrhage, Colorectal Neoplasms

NCT01606072 2015-08-28

Perioperative Use of Desmopressin (DDAVP) in Breast Cancer

Laboratorio Elea Phoenix S.A.

Phase 2 Completed
21 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡